Skip to content
Lower risk Drug recall · FDA · Published February 9, 2022

Lannett Diazepam Oral Solution Recall: Impurities May Cause Harm

Lannett recalls Diazepam Oral Solution bottles with specific lot numbers due to impurities that may cause harm. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0558-2022DrugLannett ›
Take action

Contact the company

Recalling firmLannett Company, Inc.9000 State Rd · Philadelphia, PA 19136-1615
✎ GovInfoNow plain-language explainer

Lannett is recalling Diazepam Oral Solution bottles that may contain impurities. This could cause harm if used as directed, but the recall does not specify immediate danger. Read more at govinfonow.com/recall/35227-lannett-diazepam-oral-solution-recall-impurities-may-cause-harm.

Source Summary by GovInfoNow · govinfonow.com/recall/35227-lannett-diazepam-oral-solution-recall-impurities-may-cause-harm · Updated August 18, 2026 · FDA enforcement record: FDA #D-0558-2022

Cite this page

“Lannett Diazepam Oral Solution Recall: Impurities May Cause Harm.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35227-lannett-diazepam-oral-solution-recall-impurities-may-cause-harm. Based on FDA recall #D-0558-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0558-2022%22&limit=1).

The FDA announced on Feb. 9, 2022, that Lannett Company Inc. is recalling Diazepam Oral Solution (Concentrate) due to failed impurity specifications. The recall affects 23,598 bottles distributed nationwide.

How to tell if you have it

  • Brand: Lannett
  • Product: Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER
  • NDC: 0527-1768-36
  • Lot codes: 2664A, 2664B, Exp. date 07/2022; 2874A, 2874B, Exp. date 01/2023
  • Quantity: 23,598 bottles

The hazard

The product failed to meet specifications for related substances, resulting in out-of-specification results for impurities.

Context

GovInfoNow's records show Lannett Company Inc. has 13 other recalls on record since Oct. 11, 2018. Other recent recalls of similar products include Dextroamphetamine Extended-Release Capsules (2026-06-26), Lannett Niacin Extended-release Tablets (2026-05-27), and Lannett Primidone Tablets (2026-04-24). Other recent recalls of similar products include Sun Pharmaceutical Fluocinolone Acetonide Solution (2025-12-30), Novadoz Glycopyrrolate Oral Solution (2025-12-15), and Sagent Busulfan Injection (2026-05-04).

How to tell if you have this one

Check for lot numbers 2664A, 2664B (expiring 07/2022) or 2874A, 2874B (expiring 01/2023) on the bottle. The product is a 30 mL bottle with a dropper, available by prescription.

  • Brand
    Lannett
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for lot numbers 2664A, 2664B (expiring 07/2022) or 2874A, 2874B (expiring 01/2023) on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Feb 9, 202212. FDA classified it Class II: Feb 14, 202223. Published in FDA’s Enforcement Report: Feb 23, 202234. FDA terminated the recall: May 1, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Lannett recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0558-2022 (February 9, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0558-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA